Association of Mycobacterium avium paratuberculosis With Crohn's Disease: A Large Multicenter Study From a
Sudheer Kumar Vuyyuru1, Urvashi Singh2, Prasenjit Das3
1Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
Background:
The causal relationship between Crohn's disease (CD) and Mycobacterium avium subspecies paratuberculosis (MAP) remains controversial.
Methods:
This multicenter observational study, conducted across 7 tertiary care centers in India, enrolled newly diagnosed, treatment-naive patients with CD as cases and treatment-naive patients with intestinal tuberculosis (ITB) or ulcerative colitis (UC) and healthy individuals undergoing sigmoidoscopy for hemorrhoids as controls. MAP detection was performed using serology for MAP antibodies, polymerase chain reaction (PCR), real-time quantitative PCR, and solid/liquid cultures of blood and colonic biopsy specimens. In situ PCR and immunohistochemistry were also applied to paraffin-embedded tissue sections to evaluate the presence of MAP across groups.
Results:
A total of 889 participants were recruited (148 with CD, 288 with ITB, 251 with UC, and 202 controls without inflammatory bowel disease) were included. The seropositivity of MAP was significantly higher in patients with CD than in controls (20.6% [13 of 63] vs 16.2% [12 of 74] for healthy controls, 7.8% [9 of 116] for patients with ITB, and 4.8% [4 of 84] for patients with UC; P < .01). With tissue PCR analysis using a IS900-specific sequence with colonic biopsy specimens, a significantly higher number of patients with CD were positive for MAP compared with controls (11% [9 of 82] vs 7.1% [5 of 70] for healthy controls, 1% [2 of 188] for patients with UC, and 0.5% [1 of 198] for patients with ITB; P < .01). On solid culture of biopsy samples, MAP was detected in 10% of patients with CD (5 of 50), compared with 4.1% (4 of 97) for ITB and 0% (0 of 78) for UC (P = .02). However, this difference was not observed with analysis using liquid culture, immunohistochemistry, in situ PCR, or PCR of blood samples.
Conclusions:
Our study findings suggest an increased association between MAP and CD. Future studies should explore the possible causal role of MAP in CD and potential therapeutic options to target MAP.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...